77 related articles for article (PubMed ID: 33900501)
1. Use and Costs of Sentinel Lymph Node Biopsy in Non-Ulcerated T1b Melanoma: Analysis of a Population-Based Registry.
Herb JN; Ollila DW; Stitzenberg KB; Meyers MO
Ann Surg Oncol; 2021 Jul; 28(7):3470-3478. PubMed ID: 33900501
[TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node biopsy is unreliable in predicting melanoma mortality for both younger and older patients.
Dixon AJ; Kyrgidis A; Steinman HK; Dixon JB; Sladden M; Garbe C; Lallas A; Zachary CB; Leiter-Stöppke U; Smith H; Nirenberg A; Zouboulis CC; Longo C; Argenziano G; Apalla Z; Popescu C; Tzellos T; Anderson S; Nanz L; Cleaver L; Thomas JM
J Eur Acad Dermatol Venereol; 2024 Apr; 38(4):741-751. PubMed ID: 38168748
[TBL] [Abstract][Full Text] [Related]
3. The limited value of sentinel lymph node biopsy in lentigo maligna melanoma: A nomogram based on the results of 29 years of the nationwide dutch pathology registry (PALGA).
Elshot YS; Bruijn TVM; Ouwerkerk W; Jaspars LH; van de Wiel BA; Zupan-Kajcovski B; de Rie MA; Bekkenk MW; Balm AJM; Klop WMC
Eur J Surg Oncol; 2023 Nov; 49(11):107053. PubMed ID: 37778193
[TBL] [Abstract][Full Text] [Related]
4. A Clinical Decision Tool to Calculate Pretest Probability of Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma.
Tripathi R; Larson K; Fowler G; Han D; Vetto JT; Bordeaux JS; Yu WY
Ann Surg Oncol; 2023 Jul; 30(7):4321-4328. PubMed ID: 36840860
[TBL] [Abstract][Full Text] [Related]
5. Clinical Utility of Melanoma Sentinel Lymph Node Biopsy Nomograms.
Drebin HM; Hosein S; Kurtansky NR; Nadelmann E; Moy AP; Ariyan CE; Bello DM; Brady MS; Coit DG; Marchetti MA; Bartlett EK
J Am Coll Surg; 2024 Jan; 238(1):23-31. PubMed ID: 37870230
[TBL] [Abstract][Full Text] [Related]
6. A retrospective study of sentinel lymph node biopsy for skin cancer in Japan: Comparison with breast cancer and evaluation of factors related to its use.
Wada S; Watanabe T; Ishii T; Ichinose Y; Rikitake R; Ogata D; Nakano E; Namikawa K; Yamazaki N; Higashi T
Cancer Med; 2023 Dec; 12(23):21364-21372. PubMed ID: 37902245
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node biopsy for melanoma in the older population: A prospective analysis of outcomes.
Kadhum M; Mayr L; Pope-Jones S; Cubitt J; Hemington-Gorse S
J Surg Oncol; 2024 Jun; 129(7):1202-1208. PubMed ID: 38436610
[TBL] [Abstract][Full Text] [Related]
8. Influence of Anatomic Locations of T1b Melanomas and Patient Age on Outcomes.
Huang MY; Chen A; Quarshie C; Masson R; Barajas G; Kim G; DeClerck B; Swanson MS; In GK; Kokot N; Pickering TA; Hu JC
J Drugs Dermatol; 2024 May; 23(5):306-310. PubMed ID: 38709694
[TBL] [Abstract][Full Text] [Related]
9. Is sentinel lymph node biopsy needed for lentigo maligna melanoma?
Kakish H; Lal T; Thuener JE; Bordeaux JS; Mangla A; Rothermel LD; Hoehn RS
J Surg Oncol; 2024 Mar; 129(4):804-812. PubMed ID: 38018361
[TBL] [Abstract][Full Text] [Related]
10. Sentinel Lymph Node Biopsy for Extremity and Truncal Soft Tissue Sarcomas: A Systematic Review of the Literature.
Keung EZ; Krause KJ; Maxwell J; Morris CD; Crago AM; Houdek MT; Kane J; Lewis V; Callegaro D; Miller B; Lazar AJ; Gladdy R; Raut CP; Fabbri N; Al-Refaie W; Fairweather M; Wong SL; Roland CL
Ann Surg Oncol; 2023 Feb; 30(2):958-967. PubMed ID: 36307665
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node biopsy for lentigo maligna melanoma under local anaesthesia.
Huynh J; Leiter U; Garbe C; Shiderova G; Walter V; Eigentler T; Scheu A; Häfner HM; Schnabl SM
J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):84-92. PubMed ID: 37611257
[TBL] [Abstract][Full Text] [Related]
12. The Role of Sentinel Node Biopsy in the Era of Adjuvant Therapy for Melanoma.
Brancaccio G; Briatico G; Scharf C; Colella G; Docimo G; Docimo L; Faenza M; Iovino F; Tolone S; Verolino P; Napolitano S; Troiani T; Ronchi A; Franco R; Argenziano G
Dermatol Pract Concept; 2024 Jan; 14(1):. PubMed ID: 38236993
[TBL] [Abstract][Full Text] [Related]
13. Impact of an Online Risk Calculator for Sentinel Node Positivity on Management of Patients with T1 and T2 Melanomas.
Winder AA; Boyer Z; Ch'ng S; Stretch JR; Saw RPM; Shannon KF; Pennington TE; Nieweg OE; Varey AHR; Scolyer RA; Thompson JF; Cust AE; Lo SN; Spillane AJ; Smith AL
Ann Surg Oncol; 2024 May; ():. PubMed ID: 38802717
[TBL] [Abstract][Full Text] [Related]
14. Re-biopsy of partially sampled thin melanoma impacts sentinel lymph node sampling as well as surgical margins.
Weitman ES; Perez MC; Lee D; Kim Y; Fulp W; Sondak VK; Sarnaik AA; Gonzalez RJ; Cruse CW; Messina JL; Zager JS
Melanoma Manag; 2019 Jun; 6(2):MMT17. PubMed ID: 31406562
[TBL] [Abstract][Full Text] [Related]
15. The role of organizational affiliations and research networks in the diffusion of breast cancer treatment innovation.
Carpenter WR; Reeder-Hayes K; Bainbridge J; Meyer AM; Amos KD; Weiner BJ; Godley PA
Med Care; 2011 Feb; 49(2):172-9. PubMed ID: 21206296
[TBL] [Abstract][Full Text] [Related]
16. The effect of surgical timing in nonmetastatic melanoma.
Kakish H; Drigotas C; Ahmed FA; Elshami M; Bordeaux JS; Rothermel LD; Hoehn RS
J Surg Oncol; 2024 Mar; 129(3):509-516. PubMed ID: 37985362
[TBL] [Abstract][Full Text] [Related]
17. Malignant melanoma in the hand: current evidence and recommendations.
Blessley-Redgrave N; Bowerman F; Dafydd H; Hemington-Gorse S; Boyce D
J Hand Surg Eur Vol; 2024 Apr; ():17531934241245028. PubMed ID: 38663875
[TBL] [Abstract][Full Text] [Related]
18. Cost efficacy of wide local excision of pT1a melanoma in office versus operating room settings.
Duncan JR; Srikakolapu S; Daugherty A; Elston C; Huang C; Phillips CB
J Am Acad Dermatol; 2022 May; 86(5):1174-1176. PubMed ID: 33932535
[No Abstract] [Full Text] [Related]
19. Impact of novel systemic therapies on the first-year costs of care for melanoma among Medicare beneficiaries.
Gogebakan KC; Mukherjee K; Berry EG; Sonmez K; Leachman SA; Etzioni R
Cancer; 2021 Aug; 127(16):2926-2933. PubMed ID: 33905529
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
